Status:
UNKNOWN
Pulmonary Rehabilitation Implemented With VR for Post-COVID-19 Patients
Lead Sponsor:
The Opole University of Technology
Conditions:
COVID-19
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
Although the COVID-19 pandemic was announced almost 2 years ago, societies are still facing the effects not only of individuals but also of entire populations. Clinical symptoms in patients depending ...
Detailed Description
Initial studies indicated that approximately 60 days after the first COVID-19 symptom onset, only 13% of patients previously hospitalized for COVID-19 were reported to be essentially free of any COVID...
Eligibility Criteria
Inclusion
- Individuals hospitalized for COVID-19.
Exclusion
- Failure to consent to participate in research,
- pneumonia,
- evidence of ischemic heart disease/acute changes on ECG,
- uncontrolled hypertension,
- insulin dependent diabetes mellitus,
- inability to exercise independently or musculoskeletal/neurological conditions that would prevent completion of the course,
- lung cancer,
- cognitive disorders, or Mini-Mental State Examination \< 24.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05242094
Start Date
January 1 2021
End Date
September 1 2022
Last Update
March 4 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MSWiA Specialist Hospital in Głuchołazy
Głuchołazy, Opole Voivodeship, Poland, 48-340